From Dermatological Examination to Systemic Diagnosis: Sézary Syndrome
DOI:
https://doi.org/10.24950/rspmi.2730Keywords:
Dermatitis, Exfoliative, Lymphoma, T-Cell, Cutaneous/ diagnosis, Sezary Syndrome/diagnosisDownloads
References
1. Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol. 2019;94:1027-41. doi: 10.1002/ajh.25577.
2. Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113:5064-73. doi: 10.1182/blood-2008-10-184168.
3. Thompson AK, Killian JM, Weaver AL, Pittelkow MR, Davis MD. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic. J Am Acad Dermatol. 2017;76:683-8. doi: 10.1016/j.jaad.2016.10.029.
4. Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, et al. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. Br J Dermatol. 2015;173:93-105. doi: 10.1111/bjd.13832.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Portuguese Journal Internal Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.



